Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
The syndrome of apparent mineralocorticoid excess (AME) is an inherited form of human hypertension thought to result from a deficiency of 11 beta-hydroxysteroid dehydrogenase (11 beta HSD). This enzyme normally converts cortisol to inactive cortisone and is postulated to thus confer specificity for aldosterone upon the mineralocorticoid receptor. We have analysed the gene encoding the kidney isozyme of 11 beta HSD and found mutations on both alleles in nine of 11 AME patients (eight of nine kindreds). These mutations markedly affect enzymatic activity. They thus permit cortisol to occupy the renal mineralocorticoid receptor and thereby cause sodium retention and hypertension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, the type 2 enzyme inactivates the mineralocorticoid activity of cortisol in the kidney tubule (569), and inactivating mutations in the type 2 enzyme cause a syndrome of apparent mineralocorticoid excess (AME) (588).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [588]
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
Molecular basis of human hypertension: Role of angiotensinogen
Jeunemaitre, X., Soubrier, F., Kotelevtsev, Y. V., Lifton, R. P., Williams, C. S., Charru, A., Hunt, S. C., Hopkins, P. N., Williams, R. R., Lalouel, J.-M., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90275-h · Cited by 1,850
Fetal and placental size and risk of hypertension in adult life.
Barker, D. J., Bull, A. R., Osmond, C., & Simmonds, S. J. (1990) · BMJ · doi:10.1136/bmj.301.6746.259 · Cited by 1,728
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628
Shimkets, R. A., Warnock, D. G., Bositis, C. M., Nelson-Williams, C., Hansson, J. H., Schambelan, M., Gill, J. R., Ulick, S., Milora, R. V., Findling, J. W., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90250-x · Cited by 1,259
Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H., & Russell, D. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83172-6 · Cited by 1,229
Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Research works printed but not linked: 3
- Werder, E., Zachmann, M., Völlmin, J.A., Veyrat, R. & Prader, A. Unusual steroid excretion in a child with low renin hypertension. Res. Steroids 6, 385–389 (1974).
- Winter, J.S.D. & McKenzie, J.K. (1977). A syndrome of low-renin hypertension in children. In Juvenile Hypertension (eds New, M.I. & Levin, L.S.) 123–133 (Raven Press, New York, 1977).
- Higuchi, R. Recombinant PCR. In PCR Protocols (eds Innis, M.A., Gelfand, D.H., Sninsky, J.J. & White, T.J.) 177–183 (Academic, San Diego,1990).
Cited by
Items 301–400 of 664
Morineau, G., Marc, J.-M., Boudi, A., Galons, H., Gourmelen, M., Corvol, P. L., Pascoe, L., & Fiet, J. (1999) · Hypertension · doi:10.1161/01.hyp.34.3.435 · Cited by 30
Morris, D. J., & Souness, G. W. (1996) · Endocrine Research · doi:10.1080/07435809609043778 · Cited by 30
Nashev, L. G., Vuorinen, A., Praxmarer, L., Chantong, B., Cereghetti, D., Winiger, R. R., Schuster, D., & Odermatt, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046958 · Cited by 29
Epidemiology and Genetics of Hypertension.
Sarkar, T., & Singh, N. P. (2015) · PubMed · Cited by 29
Antifungal therapy with azoles and the syndrome of acquired mineralocorticoid excess
Beck, K. R., & Odermatt, A. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111168 · Cited by 28
11β-HYDROXYSTEROID DEHYDROGENASES: A NOVEL CONTROL OF GLUCOCORTICOID ACTION IN THE BRAIN
Seckl, J. R., Yau, J. L. W., & Holmes, M. C. (2002) · Endocrine Research · doi:10.1081/erc-120016990 · Cited by 28
Baráth, Á., Endreffy, E., Bereczki, C., Gellén, B., Szücs, B., Németh, I., & Turi, S. (2007) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.94.2007.1-2.6 · Cited by 28
Ouabainlike Compound in Hypertension Associated With Ectopic Corticotropin Syndrome
Goto, A., Yamada, K., Hazama, H., Uehara, Y., Atarashi, K., Hirata, Y., Kimura, K., & Omata, M. (1996) · Hypertension · doi:10.1161/01.hyp.28.3.421 · Cited by 28
Effects of Ziram on Rat and Human 11β-Hydroxysteroid Dehydrogenase Isoforms
Li, X., Mao, B., Dong, Y., Li, Y., Zhan, M., Bai, Y., Lian, Q., Ge, R., & Ye, L. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00527 · Cited by 27
Smith, M. P., Mathur, R., Keay, S. D., Hall, L., Hull, M. G. R., & Jenkins, J. M. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00607-x · Cited by 27
Structural analysis of the 11β-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease
Zaehner, T., Plueschke, V., Frey, B. M., Frey, F. J., & Ferrari, P. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00303.x · Cited by 27
Ferrari, P., Obeyesekere, V. R., Li, K., Andrews, R. K., & Krozowski, Z. S. (1996) · Steroids · doi:10.1016/0039-128x(96)00013-x · Cited by 27
Carvajal, C. A., Tapia-Castillo, A., Valdivia, C. P., Allende, F. A., Solari, S., Lagos, C. F., Campino, C., Martínez‐Aguayo, A., Vecchiola, A., Pinochet, C., V, et al. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy051 · Cited by 26
Juvenile Hypertension, the Role of Genetically Altered Steroid Metabolism
Ferrari, P., Bianchetti, M. G., & Frey, F. J. (2001) · Hormone Research in Paediatrics · doi:10.1159/000049999 · Cited by 26
Low peripheral plasma renin activity as a critical marker in pediatric hypertension
Yiu, V., Dluhy, R., Lifton, R. P., & Guay‐Woodford, L. M. (1997) · Pediatric Nephrology · doi:10.1007/s004670050292 · Cited by 26
Kidney 11β-HSD2 Is Inhibited by Glycyrrhetinic Acid-Like Factors in Human Urine
Lo, Y. H., Sheff, M. F., Latif, S. A., Ribeiro, C., Silver, H., Brem, A. S., & Morris, D. J. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.500 · Cited by 26
A primer on the genetics of hypertension
Cusi, D., & Bianchi, G. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00007.x · Cited by 26
Rogers, S. L., Hughes, B. A., Jones, C. A., Freedman, L., Smart, K., Taylor, N., Stewart, P. M., Shackleton, C. H. L., Krone, N. P., Blissett, J., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3254 · Cited by 25
Druce, L. A., Thorpe, C., & Wilton, A. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.04.031 · Cited by 25
Genetics of the mineralocorticoid system in primary hypertension
Ferrari, P. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0048-8 · Cited by 25
Kyuma, M., Ura, N., Torii, T., Takeuchi, H., Takizawa, H., Kitamura, K., Tomita, K., Sasaki, S., & Shimamoto, K. (2001) · Clinical and Experimental Hypertension · doi:10.1081/ceh-100104238 · Cited by 25
Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues
Morris, D. J., Souness, G. W., Brem, A. S., & Rafestin-Oblin, M. E. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00977.x · Cited by 25
Effects of Aldosterone and Mineralocorticoid Receptor Blockade on Intracellular Electrolytes
Wehling, M. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-2347-z · Cited by 24
Thompson, A., Bailey, M. A., Michael, A. E., & Unwin, R. J. (2000) · Nephron Experimental Nephrology · doi:10.1159/000020647 · Cited by 24
Liu, Y., Nakagawa, Y., & Ohzeki, T. (1998) · Hypertension · doi:10.1161/01.hyp.31.3.885 · Cited by 24
Smith, R. E., Salamonsen, L. A., Komesaroff, P. A., Li, K. X. Z., Myles, K. M., Lawrence, M., & Krozowski, Z. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4451 · Cited by 22
Gordon, R. D. (1995) · Nature Genetics · doi:10.1038/ng0995-6 · Cited by 24
Renal 11β-Hydroxysteroid Dehydrogenase in Genetically Salt-Sensitive Hypertensive Rats
Takeda, Y., Inaba, S., Furukawa, K., & Miyamori, I. (1998) · Hypertension · doi:10.1161/01.hyp.32.6.1077 · Cited by 24
Inherited Disorders of the Renal Tubule
Bonnardeaux, A., & Bichet, D. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10044-2 · Cited by 23
Altuna, M. E., Lelli, S. M., de Viale, L. C. S. M., & Damasco, M. C. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-046 · Cited by 23
Pivotal Role of the Kidney in Hypertension
Hamm, L. L., & Hering-Smith, K. S. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181e590f0 · Cited by 23
Evidence for Change of 11β-Hydroxysteroid Dehydrogenase Activity during Infancy and Childhood
Dötsch, J., Hohenberger, I., Peter, M., Sippell, W. G., & Dörr, H. G. (2000) · Pediatric Research · doi:10.1203/00006450-200011000-00024 · Cited by 23
Kamide, K., Kokubo, Y., Hanada, H., Nagura, J., Yang, J., Takiuchi, S., Tanaka, C., Banno, M., Miwa, Y., Yoshii, M., et al. (2006) · Hypertension Research · doi:10.1291/hypres.29.243 · Cited by 23
The genetics of human hypertension
Crook, E. D. (2002) · Seminars in Nephrology · doi:10.1053/snep.2002.28641 · Cited by 23
Inderbinen, S. G., Zogg, M., Kley, M., Smieško, M., & Odermatt, A. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115387 · Cited by 22
11β-Hydroxysteroid dehydrogenase expression in first trimester human trophoblasts
Arcuri, F., Sestini, S., Paulesu, L. R., Bracci, L., Carducci, A., Manzoni, F. M. P., Cardone, C., & Cintorino, M. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00103-8 · Cited by 22
Craft, T. K. S., & Devries, A. C. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.054.2009 · Cited by 23
Monogenic mineralocorticoid hypertension
Stowasser, M., & Gordon, R. D. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.008 · Cited by 22
Morris, D. J., Lo, Y. H., Litchfield, W. R., & Williams, G. H. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.469 · Cited by 22
Quaschning, T., Ruschitzka, F. T., Niggli, B., Lunt, C. M., Shaw, S., Christ, M., Wehling, M., & Lüscher, T. F. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.11.2146 · Cited by 22
Programming of adrenocortical function and the fetal origins of adult disease
Phillips, D. I. W. (2001) · Journal of Endocrinological Investigation · doi:10.1007/bf03343920 · Cited by 22
Renal Sodium Handling for Body Fluid Maintenance and Blood Pressure Regulation
Matsubara, M. (2004) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.124.301 · Cited by 21
Maser, E. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90642-8 · Cited by 21
NaCl transport deficiencies – hemodynamics to the rescue
Schnermann, J. B. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240000258 · Cited by 21
Woods, C. P., & Tomlinson, J. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2895-8_16 · Cited by 20
Støving, R. K., Lingqvist, L. E., Bonde, R. K., Andries, A., Hansen, M. H., Andersen, M., & Hørder, K. (2010) · Nutrition · doi:10.1016/j.nut.2010.06.006 · Cited by 20
Forms of Mineralocorticoid Hypertension
Ferrari, P., & Bonny, O. (2003) · Vitamins and hormones · doi:10.1016/s0083-6729(03)01004-5 · Cited by 20
Monogenic hypertension: Lessons from the genome
Luft, F. C. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00810.x · Cited by 20
Contemporary management of refractory hypertension
Alper, A., & Calhoun, D. A. (1999) · Current Hypertension Reports · doi:10.1007/s11906-999-0055-0 · Cited by 20
Alzahrani, A. S., Aljuhani, N. R., Qasem, E., Almohanna, M., Hamoudh, E., Al-Omair, A., & Al-Harbi, N. (2014) · Endocrine Practice · doi:10.4158/ep14094.cr · Cited by 19
ENaC Modulators and Renal Disease
de la Rosa, D. Á., Navarro‐González, J. F., & Giráldez, T. (2013) · Current Molecular Pharmacology · doi:10.2174/1874467211306010005 · Cited by 19
Monogenic Hypertension in Children: A Review With Emphasis on Genetics
Aggarwal, A., & Rodriguez‐Buritica, D. (2017) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.09.006 · Cited by 19
Endocrine Disorders of Sodium Regulation
Kuhnle, U., Lewicka, S., & Fuller, P. J. (2004) · Hormone Research in Paediatrics · doi:10.1159/000075242 · Cited by 19
A Practical Approach to Genetic Hypokalemia
Lin, S., Yang, S.-S., & Chau, T. (2010) · Electrolytes & Blood Pressure · doi:10.5049/ebp.2010.8.1.38 · Cited by 19
Molecular medicine of steroid hormone biosynthesis
Biason‐Lauber, A. (1998) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(98)00004-1 · Cited by 19
Investigation of hypertension and the recognition of monogenic hypertension
Milford, D. V. (1999) · Archives of Disease in Childhood · doi:10.1136/adc.81.5.452 · Cited by 19
Development of Function in the Metanephric Kidney
Satlin, L. M., Woda, C. B., & Schwartz, G. J. (2003) · Elsevier eBooks · doi:10.1016/b978-012722441-1/50020-8 · Cited by 19
Genetic Alterations in Patients with Primary Aldosteronism.
Takeda, Y. (2001) · Hypertension Research · doi:10.1291/hypres.24.469 · Cited by 19
Zhao, C., Wang, S., Zhai, Y., Wang, M., Tang, Y., Li, H., Im, Y. J., & Ge, R. (2022) · Toxicology · doi:10.1016/j.tox.2023.153484 · Cited by 18
Mineralocorticoid and Apparent Mineralocorticoid Syndromes of Secondary Hypertension
Ardhanari, S., Kannuswamy, R., Chaudhary, K. R., Lockette, W. E., & Whaley‐Connell, A. T. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2015.03.002 · Cited by 18
Corticosteroid-dependent hypertension: environmental influences
Odermatt, A. (2004) · Swiss Medical Weekly · doi:10.4414/smw.2004.10372 · Cited by 18
Urinary cortisol to cortisone metabolites in hypertensive obese children
Csábí, G., Juricskay, S., & Molnár, D. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343752 · Cited by 18
Krozowski, Z. S., Stewart, P. M., Obeyesekere, V. R., Li, K., & Ferrari, P. (1997) · Clinical and Experimental Hypertension · doi:10.3109/10641969709083166 · Cited by 18
Wang, Y., Wang, J., Yang, R., Wang, P., Porche, R., Kim, S., Lutfy, K., Liu, L., Friedman, T. C., Jiang, M., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16458 · Cited by 17
Physiologic roles of 11β-hydroxysteroid dehydrogenase type 2 in kidney
Isomura, Y., Mune, T., Morita, H., Suwa, T., Takada, N., Yamamoto, Y., & Takeda, J. (2006) · Metabolism · doi:10.1016/j.metabol.2006.06.005 · Cited by 17
Self-citationEvaluation of selective inhibitors of 11β-HSD1 for the treatment of hypertension
Bauman, D. R., Whitehead, A., Contino, L. C., Cui, J., Garcia-Calvo, M. M., Gu, X., Kevin, N. J., Ma, X., Pai, L.-Y., Shah, K., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.011 · Cited by 17
Pathophysiology, Diagnosis, and Treatment of Mineralocorticoid Disorders
Magill, S. B. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130042 · Cited by 17
Jiménez-Canino, R., Lorenzo-Díaz, F., Odermatt, A., Bailey, M. A., Livingstone, D. E. W., Jaisser, F., Farman, N., & de la Rosa, D. Á. (2017) · Endocrinology · doi:10.1210/en.2017-00440 · Cited by 17
Gupta, T., Connors, M., Tan, J. W., Manosroi, W., Ahmed, N., Ting, P. Y., Garza, A., Romero, J. R., Hopkins, P. N., Williams, J. S., et al. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx146 · Cited by 17
Novel metabolomic profile of subjects with non-classic apparent mineralocorticoid excess
Tapia-Castillo, A., Carvajal, C. A., López-Cortés, X. A., Vecchiola, A., & Fardella, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-96628-6 · Cited by 17
Screening for genetic causes of hypertension
Dluhy, R. G. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0023-4 · Cited by 17
Campbell, L. E., Yu, M., & Yang, K. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(96)03775-6 · Cited by 17
Lin‐Su, K., Zhou, P., Arora, N., Betensky, B. P., New, M. I., & Wilson, R. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031268 · Cited by 17
Stölting, G., Vo, K. N. T., Haus, J., & Scholl, U. I. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-01020-6 · Cited by 17
Licorice-induced hypertension and common variants of genes regulating renal sodium reabsorption
Miettinen, H. E., Piippo, K., Hannila‐Handelberg, T., Paukku, K., Hiltunen, T. P., Gautschi, I., Schild, L., & Kontula, K. (2010) · Annals of Medicine · doi:10.3109/07853890.2010.499133 · Cited by 16
Genomic Approaches to Hypertension
Dodoo, S., & Benjamin, I. J. (2017) · Cardiology Clinics · doi:10.1016/j.ccl.2016.12.001 · Cited by 16
A novel mutation in HSD11B2 causes apparent mineralocorticoid excess in an Omani kindred
Yau, M., Azkawi, H. S. A., Haider, S. M., Khattab, A., Badi, M. A., Abdullah, W., Senani, A. A., Wilson, R. C., Yuen, T., Zaidi, M., et al. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13162 · Cited by 15
Miyama, N., Hasegawa, Y., Suzuki, M., Hida, W., Kazama, I., Hatano, R., Sanada, S., Arata, T., Michimata, M., Sato, A., et al. (2007) · Clinical and Experimental Hypertension · doi:10.1080/10641960601096968 · Cited by 15
Linkage mapping for hypertension susceptibility genes
Kato, N., & Julier, C. (1999) · Current Hypertension Reports · doi:10.1007/s11906-999-0069-7 · Cited by 15
Koyama, K., & Krozowski, Z. S. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00548-2 · Cited by 15
11β-Hydroxysteroid dehydrogenases: key modulators of glucocorticoid action in vivo
Kotelevtsev, Y. V., Seckl, J. R., & Mullins, J. J. (1999) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-199906000-00004 · Cited by 15
Lin, L., & Achermann, J. C. (2004) · Hormone Research in Paediatrics · doi:10.1159/000080495 · Cited by 16
Rogoff, D., Smolenicka, Z., Bergadá, I., Vallejo, G., Barontini, M., Heinrich, J. J., & Ferrari, P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5329 · Cited by 15
A case of renin-producing adrenocortical cancer
YAMANAKA, K., IITAKA, M., INABA, M., MORITA, T., SASANO, H., & KATAYAMA, S. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.119 · Cited by 14
Morris, D. J., Brem, A. S., & Odermatt, A. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105988 · Cited by 14
Molecular genetics of human hypertension
Luft, F. C. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000722 · Cited by 14
Clinical Syndromes of Metabolic Alkalosis
Moe, O. W., Alpern, R. J., & Seldin, D. W. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00058-6 · Cited by 14
Melander, O., Frandsen, E., Groop, P., & Hulthén, U. L. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00981-6 · Cited by 14
Zearalenone Inhibits Rat and Human 11β-Hydroxysteroid Dehydrogenase Type 2
Li, L., Wu, X., Guan, H., Mao, B., Wang, H., Yuan, X., Chu, Y., Sun, J., & Ge, R. (2015) · BioMed Research International · doi:10.1155/2015/283530 · Cited by 14
The epithelial sodium channel in hypertension
Warnock, D. G. (1999) · Current Hypertension Reports · doi:10.1007/s11906-999-0013-x · Cited by 14
Pathophysiological roles of vascular 11β-hydroxysteroid dehydrogenase and aldosterone
Takeda, Y. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00216-4 · Cited by 14
Segal, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3770-3_3 · Cited by 13
Uneda, K., Kawai, Y., Kaneko, A., Kayo, T., Akiba, S., Ishigami, T., Yoshida‐Komiya, H., Suzuki, M., & MITSUMA, T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296450 · Cited by 13
Life after liquorice: the link between cortisol and conception
Michael, A. E. (2003) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)62091-3 · Cited by 13
Fetal Programming of Stress Responses
Ward, A. M. V., & Phillips, D. I. W. (2001) · Stress · doi:10.3109/10253890109014750 · Cited by 13
Hofmann, M., Pollow, K., Bahlmann, F., Casper, F. W., Steiner, E., & Brockerhoff, P. (2001) · Journal of Perinatal Medicine · doi:10.1515/jpm.2001.003 · Cited by 13
11β-hydroxystéroïde déshydrogénases. Avancées récentes
Vantyghem, M., Marcelli-Tourvieille, S., Defrance, F., & Wémeau, J.-L. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.02.003 · Cited by 13
Martínez‐Aguayo, A., Carvajal, C. A., Campino, C., Marlene Aglony, I., Bolte, L., García, H., & Fardella, C. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.052 · Cited by 12
Evidence for a role of sterol 27-hydroxylase in glucocorticoid metabolism in vivo
Vögeli, I., Jung, H. H., Dick, B., Erickson, S. K., Escher, R., Funder, J. W., Frey, F. J., & Escher, G. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0141 · Cited by 12
Vantyghem, M., Ghulam, A., Hober, C., Schoonberg, C., D’Herbomez, M., Racadot, A., Boersma, A., & Lefèbvre, J. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03347306 · Cited by 12
Metadata
- Authors
- Mune, T., Rogerson, F. M., Nikkilä, H., Agarwal, A. K., & White, P. C.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature Genetics
- Published
- 1995-08-01
- Volume
- 10
- Issue
- 4
- Pages
- 394-399
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2034652601
- Semantic Scholar
- 39186032ea056bd01960beb7624e326d14d1cda1
- Cited by
- 619
- References
- 57
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 10 · 2022: 4 · 2021: 12 · 2020: 8 · 2019: 9 · 2018: 9 · 2017: 13 · 2016: 15 · 2015: 16 · 2014: 13 · 2013: 15 · 2012: 15
- FWCI
- 33.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk034400-10, 5r01dk042169-12)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK42169, DK-34400)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- apparent mineralocorticoid excess, hypertension, 11β-hydroxysteroid dehydrogenase, genetic mutations, mineralocorticoid receptor, cortisol, aldosterone, sodium retention, genetic hypertension, kindred
- MeSH terms
- Adolescent, Adult, Base Sequence, Child, Child, Preschool, Female, Humans, Hydroxysteroid Dehydrogenases, Hypertension, Infant, Infant, Low Birth Weight, Infant, Newborn, Isoenzymes, Kidney, Male, Mineralocorticoids, Molecular Sequence Data, Mutation, Risk Factors, DNA Primers, 11-beta-Hydroxysteroid Dehydrogenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.